PROTEIN SEQUENCING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Protein sequencing is a crucial technique used in the field of biochemistry and molecular biology to determine the order of amino acids in a protein. This process helps in understanding the structure and function of proteins, which are essential in various biological processes. Protein sequencing plays a significant role in pharmaceutical research, biotechnology, and personalized medicine.

The global protein sequencing market has been witnessing significant growth due to the increasing demand for protein-based therapeutics, advancements in proteomics research, and the rising prevalence of chronic diseases. Moreover, the increasing focus on precision medicine and personalized treatments is also driving the market growth. For instance, on September 12 2023, Olink Holding AB, a company dedicated to accelerating proteomics, announced the collaboration with Eurofins Genomics, a division of Eurofins Scientific Group, to bolster its offerings in the fields of research, population health, and regulated clinical trials through the application of Olink technology.

Similarly, in March 2022, Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced the launch of its expanded suite of proteomics platforms that provide pharmaceutical and diagnostics customers with deep biological insights across the entire R&D pipeline, from early stage discovery to clinical settings.

Market Dynamics:

The protein sequencing market is driven by several factors. Firstly, the growing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, has led to an increased demand for protein-based therapies. Protein sequencing plays a critical role in drug discovery and development, enabling researchers to understand the mechanisms of diseases and develop targeted therapies. For instance, according to data published by Centers for Disease Control and Prevention, more than 1 in 7 US adults–about 35.5 million people, or 14%–are estimated to have Chronic Kidney Disease (CKD). CKD is more common in people aged 65 years or older (34%) than in people aged 45–64 years (12%) or 18–44 years (6%).

Additionally, the advancements in proteomics research have opened up new opportunities for the protein sequencing market. The development of high-throughput technologies, such as mass spectrometry and next-generation sequencing, has revolutionized the field of proteomics, making protein sequencing more accessible and efficient.

However, there are certain challenges and restraints faced by the protein sequencing market. The high cost of protein sequencing instruments and reagents is one of the major hindrances to the market growth. Moreover, the complexity and variability of protein structures pose technical challenges in accurate and reliable protein sequencing.

Nevertheless, the protein sequencing market presents several opportunities for growth. The increasing investment in research and development activities, particularly in emerging economies, is likely to create new prospects for market players. Additionally, the rise in personalized medicine and the need for targeted therapies are expected to drive the demand for protein sequencing in the future.

Key Features of the Study:

• This report provides in-depth analysis of the global protein sequencing market, including market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), with 2022 as the base year.
• It elucidates potential revenue opportunities across different market segments and presents attractive investment proposition matrices for stakeholders.
• The study provides key insights into market drivers, restraints, opportunities, market trends, and competitive strategies adopted by key players in the protein sequencing market.
• Key players in the global protein sequencing market are profiled based on parameters such as company highlights, product portfolios, financial performance, and strategies.
• The key companies covered in this study include Agilent Technologies, Thermo Fisher Scientific, SGS S.A., Shimadzu Corp, Waters Corp., Bio-Rad Laboratories, Bruker Corporation, Charles River Laboratories, Selvita, and Rapid Novor Inc.
• The report enables marketers and management authorities to make informed decisions regarding future product launches, market expansion, and marketing tactics.
• Various stakeholders in the protein sequencing industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts, can benefit from the insights provided.
• Strategy matrices used in analyzing the global protein sequencing market will assist stakeholders in making informed decisions.

Protein Sequencing Market Segmentation:

• By Technology
• • Edman Degradation
  • Mass Spectrometry
  • Others
• By Product
• • Instruments
  • Reagents, Kits & Consumables
  • Software & Services
• By Application
• • Academic Research
  • Clinical Diagnosis
  • Biopharmaceuticals
  • Others
• By End user
• • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations
• By Region
• • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Top Companies in Protein Sequencing Market:
• • Agilent Technologies
  • Thermo Fisher Scientific
  • SGS S.A.
  • Shimadzu Corp
  • Waters Corp.
  • Bio-Rad Laboratories
  • Bruker Corporation
  • Charles River Laboratories
  • Selvita
  • Rapid Novor Inc.